Recent studies have reported that some anti-diabetes drugs may have beneficial effects in HF, including dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and SGLT-2 inhibitors. Here, GLP1R is linked to diabetes mellitus.